Trial Comparing Elan Specialized Bariatric Supplements With Standard Multivitamins in Patients Undergoing Bariatric Procedures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

624 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obesity has escalated to pandemic levels, impacting over 650 million adults globally and significantly contributing to the burden of non-communicable diseases such as type 2 diabetes, cardiovascular disease, obstructive sleep apnea, non-alcoholic fatty liver disease, and infertility. The chronic, multifactorial nature of obesity presents substantial challenges for long-term management, as lifestyle modifications and pharmacotherapy often yield limited and transient success. In this context, Metabolic and bariatric surgery (MBS) has emerged as the most effective and enduring treatment for obesity, offering significant weight loss and marked improvement or remission of obesity-related comorbidities.

The most prevalent MBS procedures include sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB). While these interventions offer considerable metabolic advantages, they inherently cause significant modifications to gastrointestinal anatomy and physiology, which can predispose patients to long-term micronutrient deficiencies. These deficiencies can stem from reduced dietary intake, altered gastric acid secretion, decreased intrinsic factor production, and the bypassing of critical absorptive sites in the gastrointestinal tract. Commonly affected nutrients encompass iron, vitamin B12, Vitamin B6, folate, vitamin D, calcium, and zinc. If not effectively managed, these nutrient deficiencies can lead to anemia, secondary hyperparathyroidism, osteopenia, neurological complications, immune dysfunction, and impaired postoperative recovery.

Population-based recommended dietary allowances (RDAs) and tolerable upper intake levels (ULs) tend to underestimate the nutritional requirements for postoperative patients, as they are derived from healthy cohorts. Many standard formulations may fall short due to inadequate dosages, non-bioavailable forms, or poor tolerability, which can significantly impact patient adherence to supplementation regimens. Over-the-counter multivitamins, such as Centrum®, are designed for the general population and often lack the dosing, bioavailability, or elemental forms required for post-MBS physiology, particularly following bypass procedures.

The American Society for Metabolic and Bariatric Surgery (ASMBS) recommends 8-22 mg of elemental zinc per day, depending on the procedure, and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the World Gastroenterology Organization (WGO) recommend up to 30 mg/day for OAGB patients. These values are below the national upper limit in Egypt, which is 25 mg/day.

Moreover, there is evidence indicating a discrepancy in nutrient deficiencies among different bariatric surgery patients; for instance, OAGB patients exhibit a greater prevalence of iron and zinc deficiencies compared to those undergoing RYGB or SG, thereby necessitating proportionally higher supplementation tailored to their specific needs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Randomized Controlled Trial Evaluating the Impact of Procedure-Specific Bariatric Supplements on Micronutrient Status and Vitamin B6 Hypervitaminosis Following Metabolic and Bariatric Surgery

NCT07021248

Micronutrient Status

RECRUITING PHASE4

Vitamin and Mineral Supplementation Post Bariatric Surgery

NCT02817256

Complications of Other Bariatric Procedure

UNKNOWN NA

Multivitamin Support Following Bariatric Surgery

NCT06152965

Bariatric Surgery

COMPLETED

Dietary Fibers and Satiety in Bariatric Patients

NCT03573258

Bariatric Surgery Candidate

COMPLETED NA

Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients

NCT03360435

Bariatric Surgery Candidate Vitamin Deficiency Mineral Deficiency

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consequently, specialized supplements containing adjusted doses of iron, zinc, and copper, within or slightly exceeding international guideline recommendations, are proposed to address the heightened risk of deficiencies, particularly in MBS procedures such as RYGB and OAGB, which are both clinically necessary and scientifically supported. In response to these shortcomings, specialized MBS supplements have been formulated to meet the unique physiological requirements and anatomical changes associated with each surgical procedure. The Elan Bariatric Supplement line, featuring Elan Believe for sleeve gastrectomy, Elan Compass for Roux-en-Y gastric bypass, and Elan Supreme for omega-loop gastric bypass, illustrates this tailored approach. It combines procedure-specific formulations aimed at optimizing nutrient absorption, minimizing gastrointestinal side effects, and enhancing patient compliance.

Despite the theoretical benefits of these specialized formulations, robust evidence supporting their clinical superiority over standard multivitamins remains scarce. Randomized controlled trials are warranted to ascertain whether these tailored supplements lead to improved nutritional status, enhanced tolerability, and superior overall outcomes in the post-MBS population. The present study intends to bridge this gap by evaluating the incidence of micronutrient deficiencies, along with biochemical and clinical outcomes, and patient compliance over 12 months between individuals receiving specialized Elan supplements and those utilizing standard multivitamins following SG, RYGB, and OAGB. This trial will stratify its analysis based on the type of surgery to assess the differential impacts of supplementation per the distinct anatomical and absorptive characteristics of these three procedures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin Deficiencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants enrolled in the trial will receive one of two oral multivitamin regimens for a total duration of 12 months, commencing on postoperative day 30. Within each surgical subgroup, including SG, RYGB, and OAGB, participants will be randomized in a 1:1 ratio to receive either a specialized bariatric supplement or a standard over-the-counter multivitamin.

The specialized supplements, developed by Elan, include Elan Believe, Elan Compass, and Elan Supreme. Elan Believe is formulated specifically for patients undergoing SG, Elan Compass is tailored for RYGB and Elan Supreme, designed for OAGB. These zinc levels are aligned with ASMBS recommendations for SG and RYGB and slightly exceed the IFSO guideline of 30 mg/day for OAGB.

The comparator supplement is a commercially available, over-the-counter multivitamin containing 100% of the recommended daily allowance (RDA) for essential vitamins and minerals.

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elan in Patients Undergoing Sleeve Gastrectomy

Patients undergoing sleeve gastrectomy and administrating Elan Specialized Bariatric Supplements (Elan Believe)

Group Type ACTIVE_COMPARATOR